Glucose-6-phosphate dehydrogenase deficiency risk factors: Difference between revisions
No edit summary |
No edit summary |
||
Line 21: | Line 21: | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of G6PD deficiency include some foods such as fava beans, some medications and infections. | |||
Common risk factors in the development of | |||
===Common Risk Factor=== | ===Common Risk Factor=== | ||
*Common risk factors in the development of G6PD include: | *Common risk factors in the development of G6PD include: | ||
**Foods such as fava beans in G6PD mutation carriers | **Foods such as [[Fava bean|fava]] beans in G6PD [[mutation]] carriers | ||
**Medications such as: <ref name="pmid29262208">{{cite journal |vauthors=Richardson SR, O'Malley GF |title= |journal= |volume= |issue= |pages= |date= |pmid=29262208 |doi= |url=}}</ref> | **Medications such as: <ref name="pmid29262208">{{cite journal |vauthors=Richardson SR, O'Malley GF |title= |journal= |volume= |issue= |pages= |date= |pmid=29262208 |doi= |url=}}</ref> | ||
***Aspirin | ***[[Aspirin]] | ||
***Antimalarials: quinine, primaquine, pamaquine, and chloroquine | ***[[Antimalarial drug|Antimalarials]]: [[quinine]], [[primaquine]], [[pamaquine]], and [[chloroquine]] | ||
***Sulfonamides: mafenide, sulfanilamide, sulfamethoxazole | ***[[Sulfonamides]]: [[mafenide]], [[sulfanilamide]], [[sulfamethoxazole]] | ||
***Thiazolesulfone | ***Thiazolesulfone | ||
***Methylene blue | ***Methylene blue | ||
***Analgesics: phenazopyridine and acetanilide | ***[[Analgesic|Analgesics]]: [[phenazopyridine]] and [[acetanilide]] | ||
***Rasburicase | ***[[Rasburicase]] | ||
***Some non-sulfa antibiotics such as furazolidone, isoniazid, dapsone, nalidixic acid, nitrofurantoin). | ***Some non-sulfa antibiotics such as [[furazolidone]], [[isoniazid]], [[dapsone]], [[nalidixic acid]], [[nitrofurantoin]]). | ||
***High dose vitamin C | ***High dose [[vitamin C]] | ||
*** | *** | ||
**Bacterial, viral and rickettsial infection | **[[Bacterial]], [[viral]] and [[rickettsial]] infection | ||
**Some chemicals: Hanna in tattos and hair dyes.<ref name="pmid11668106">{{cite journal |vauthors=Raupp P, Hassan JA, Varughese M, Kristiansson B |title=Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency |journal=Arch. Dis. Child. |volume=85 |issue=5 |pages=411–2 |date=November 2001 |pmid=11668106 |pmc=1718961 |doi= |url=}}</ref> | **Some chemicals: Hanna in tattos and hair dyes.<ref name="pmid11668106">{{cite journal |vauthors=Raupp P, Hassan JA, Varughese M, Kristiansson B |title=Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency |journal=Arch. Dis. Child. |volume=85 |issue=5 |pages=411–2 |date=November 2001 |pmid=11668106 |pmc=1718961 |doi= |url=}}</ref> | ||
** | ** | ||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
*Less common risk factors in the development of G6PD include: | *Less common risk factors in the development of G6PD include: | ||
**Moth balls (naphthalene) | **Moth balls ([[naphthalene]]) | ||
** | ** | ||
**Diabetic ketoacidosis<ref name="pmid4623682">{{cite journal |vauthors=Gellady AM, Greenwood RD |title=G-6-PD hemolytic anemia complicating diabetic ketoacidosis |journal=J. Pediatr. |volume=80 |issue=6 |pages=1037–8 |date=June 1972 |pmid=4623682 |doi= |url=}}</ref> | **[[Diabetic ketoacidosis]]<ref name="pmid4623682">{{cite journal |vauthors=Gellady AM, Greenwood RD |title=G-6-PD hemolytic anemia complicating diabetic ketoacidosis |journal=J. Pediatr. |volume=80 |issue=6 |pages=1037–8 |date=June 1972 |pmid=4623682 |doi= |url=}}</ref> | ||
**Amyl nitrite or isobutyl nitrite in RUSH ( sexual enhancement drug)<ref name="pmid8081534">{{cite journal |vauthors=Beaupre SR, Schiffman FJ |title=Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use |journal=Arch Fam Med |volume=3 |issue=6 |pages=545–8 |date=June 1994 |pmid=8081534 |doi= |url=}}</ref> | **[[Amyl nitrite]] or [[isobutyl nitrite]] in RUSH ( sexual enhancement drug)<ref name="pmid8081534">{{cite journal |vauthors=Beaupre SR, Schiffman FJ |title=Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use |journal=Arch Fam Med |volume=3 |issue=6 |pages=545–8 |date=June 1994 |pmid=8081534 |doi= |url=}}</ref> | ||
** | ** | ||
Revision as of 17:11, 27 August 2018
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glucose-6-phosphate dehydrogenase deficiency risk factors On the Web |
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency risk factors |
FDA on Glucose-6-phosphate dehydrogenase deficiency risk factors |
CDC on Glucose-6-phosphate dehydrogenase deficiency risk factors |
Glucose-6-phosphate dehydrogenase deficiency risk factors in the news |
Blogs on Glucose-6-phosphate dehydrogenase deficiency risk factors |
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
Risk calculators and risk factors for Glucose-6-phosphate dehydrogenase deficiency risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
Common risk factors in the development of G6PD deficiency include some foods such as fava beans, some medications and infections.
Common Risk Factor
- Common risk factors in the development of G6PD include:
- Foods such as fava beans in G6PD mutation carriers
- Medications such as: [1]
- Aspirin
- Antimalarials: quinine, primaquine, pamaquine, and chloroquine
- Sulfonamides: mafenide, sulfanilamide, sulfamethoxazole
- Thiazolesulfone
- Methylene blue
- Analgesics: phenazopyridine and acetanilide
- Rasburicase
- Some non-sulfa antibiotics such as furazolidone, isoniazid, dapsone, nalidixic acid, nitrofurantoin).
- High dose vitamin C
- Bacterial, viral and rickettsial infection
- Some chemicals: Hanna in tattos and hair dyes.[2]
Less Common Risk Factors
- Less common risk factors in the development of G6PD include:
- Moth balls (naphthalene)
- Diabetic ketoacidosis[3]
- Amyl nitrite or isobutyl nitrite in RUSH ( sexual enhancement drug)[4]
References
- ↑ Richardson SR, O'Malley GF. PMID 29262208. Missing or empty
|title=
(help) - ↑ Raupp P, Hassan JA, Varughese M, Kristiansson B (November 2001). "Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency". Arch. Dis. Child. 85 (5): 411–2. PMC 1718961. PMID 11668106.
- ↑ Gellady AM, Greenwood RD (June 1972). "G-6-PD hemolytic anemia complicating diabetic ketoacidosis". J. Pediatr. 80 (6): 1037–8. PMID 4623682.
- ↑ Beaupre SR, Schiffman FJ (June 1994). "Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use". Arch Fam Med. 3 (6): 545–8. PMID 8081534.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [4]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Risk Factors
- Ethnic groups
- African American
- Middle Eastern decent, particularly Kurdish or Sephardic Jewish
- Male
- Family history of the deficiency